Vericel to Host Second-Quarter 2017 Earnings Webcast and Conference Call on August 9, 2017
July 26, 2017 08:00 ET
|
Vericel Corporation
CAMBRIDGE, Mass., July 26, 2017 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leading developer of autologous expanded cell therapies for the treatment of patients with serious diseases...
Vericel to Host Symposium on MACI Implant for Treating Articular Cartilage Defects in the Knee at AOSSM 2017 Annual Meeting
July 13, 2017 08:00 ET
|
Vericel Corporation
CAMBRIDGE, Mass., July 13, 2017 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leading developer of expanded autologous cell therapies for the treatment of patients with serious diseases...
Vericel Reports First-Quarter 2017 Financial Results
May 10, 2017 07:00 ET
|
Vericel Corporation
CAMBRIDGE, Mass., May 10, 2017 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leading developer of autologous expanded cell therapies for the treatment of patients with serious diseases...
Vericel Licenses Product Portfolio to Innovative Cellular Therapeutics for Distribution in China, South Korea, and other Countries in Southeast Asia
May 10, 2017 07:00 ET
|
Vericel Corporation
CAMBRIDGE, Mass. and SHANGHAI, China, May 10, 2017 (GLOBE NEWSWIRE) -- Vericel Corporation (Nasdaq:VCEL), a leading developer of expanded autologous cell therapies for the treatment of patients with...
Vericel Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Ixmyelocel-T for the Treatment of Advanced Heart Failure Due to Ischemic Dilated Cardiomyopathy
May 10, 2017 07:00 ET
|
Vericel Corporation
CAMBRIDGE, Mass., May 10, 2017 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leading developer of autologous expanded cell therapies for the treatment of patients with serious diseases...
Vericel to Host First-Quarter 2017 Earnings Webcast and Conference Call on May 10, 2017
May 04, 2017 15:20 ET
|
Vericel Corporation
CAMBRIDGE, Mass., May 04, 2017 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leading developer of autologous expanded cell therapies for the treatment of patients with serious diseases...
Vericel to Present at the 5th Annual Cell & Gene Therapy Investor Day
April 20, 2017 11:03 ET
|
Vericel Corporation
CAMBRIDGE, Mass., April 20, 2017 (GLOBE NEWSWIRE) -- Vericel Corporation (Nasdaq:VCEL), a leading developer of expanded autologous cell therapies for the treatment of patients with serious diseases...
Vericel Announces Appointment of Michael Halpin as Senior Vice President, Quality and Regulatory Affairs
April 10, 2017 09:19 ET
|
Vericel Corporation
CAMBRIDGE, Mass., April 10, 2017 (GLOBE NEWSWIRE) -- Vericel Corporation (Nasdaq:VCEL), a leading developer of expanded autologous cell therapies for the treatment of patients with serious diseases...
Vericel to Present at the 16th Annual Needham Healthcare Conference
March 28, 2017 08:00 ET
|
Vericel Corporation
CAMBRIDGE, Mass., March 28, 2017 (GLOBE NEWSWIRE) -- Vericel Corporation (Nasdaq:VCEL), a leading developer of expanded autologous cell therapies for the treatment of patients with serious diseases...
Outcomes Data From Over 950 Severe Burn Patients Treated With Epicel Presented at the 49th Annual Meeting of the American Burn Association
March 23, 2017 10:15 ET
|
Vericel Corporation
CAMBRIDGE, Mass., March 23, 2017 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leading developer of expanded autologous cell therapies for the treatment of patients with serious diseases...